STARR Trademark

Trademark Overview

On Friday, January 17, 2020, a trademark application was filed for STARR with the United States Patent and Trademark Office. The USPTO has given the STARR trademark a serial number of 88763664. The federal status of this trademark filing is REGISTERED as of Tuesday, July 11, 2023. This trademark is owned by Arcturus Therapeutics, Inc.. The STARR trademark is filed in the Pharmaceutical Products category with the following description:

Biological compound for medical use, namely, enhanced ribonucleic acid delivered into patient cells; Biological compounds being a component in vaccines; Therapeutic agents for generating protective immune response; Molecularly engineered RNA for increasing expression, and extending duration of expression, of therapeutic proteins upon delivery into patient cells
starr

General Information

Serial Number88763664
Word MarkSTARR
Filing DateFriday, January 17, 2020
Status700 - REGISTERED
Status DateTuesday, July 11, 2023
Registration Number7108233
Registration DateTuesday, July 11, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 26, 2020

Trademark Statements

Goods and ServicesBiological compound for medical use, namely, enhanced ribonucleic acid delivered into patient cells; Biological compounds being a component in vaccines; Therapeutic agents for generating protective immune response; Molecularly engineered RNA for increasing expression, and extending duration of expression, of therapeutic proteins upon delivery into patient cells

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 23, 2020
Primary Code005
First Use Anywhere DateMonday, May 15, 2023
First Use In Commerce DateMonday, May 15, 2023

Trademark Owner History

Party NameArcturus Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameArcturus Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameArcturus Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Tuesday, July 11, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 11, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, June 7, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 6, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, June 2, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, June 1, 2023USE AMENDMENT FILED
Thursday, June 1, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, January 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 23, 2023SOU EXTENSION 5 GRANTED
Thursday, January 5, 2023SOU EXTENSION 5 FILED
Monday, January 23, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 5, 2023SOU TEAS EXTENSION RECEIVED
Saturday, July 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 14, 2022SOU EXTENSION 4 GRANTED
Thursday, July 14, 2022SOU EXTENSION 4 FILED
Thursday, July 14, 2022SOU TEAS EXTENSION RECEIVED
Friday, January 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 19, 2022SOU EXTENSION 3 GRANTED
Wednesday, January 19, 2022SOU EXTENSION 3 FILED
Wednesday, January 19, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, June 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 28, 2021SOU EXTENSION 2 GRANTED
Monday, June 28, 2021SOU EXTENSION 2 FILED
Monday, June 28, 2021SOU TEAS EXTENSION RECEIVED
Thursday, January 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 5, 2021SOU EXTENSION 1 GRANTED
Tuesday, January 5, 2021SOU EXTENSION 1 FILED
Tuesday, January 5, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, July 21, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 26, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 26, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 6, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 17, 2020ASSIGNED TO LIE
Tuesday, April 7, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 7, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, April 7, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, April 7, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, April 7, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, April 6, 2020ASSIGNED TO EXAMINER
Thursday, January 23, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 21, 2020NEW APPLICATION ENTERED

Related Keywords

starr cells biological expression patient therapeutic engineered increasing molecularly response immune